Abstract Details
Vicki L. Wheelock, MD
(UC Davis Department of Neurology)
PRESENTER |
Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME Continuing Medical 好色先生. |
No disclosure on file | |
Alexandra O. Duffy, MD, FAAN (UC Davis Health) | Dr. Duffy has nothing to disclose. |
No disclosure on file | |
No disclosure on file | |
Ashok J. Dayananthan, MD (Sutter Medical Group) | No disclosure on file |
No disclosure on file | |
Sarah Farias (University of California, Davis) | No disclosure on file |
No disclosure on file | |
Charles S. DeCarli, MD, FAAN (UC Davis Health - Dept of NeurologyAlzheimer's Disease Research Center) | Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH. |
James A. Brunberg, MD (UC Davis Medical Center) | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Steven M. Hersch, MD, PhD (Eisai Inc.) | Dr. Hersch has received personal compensation for serving as an employee of Eisai Inc.. Dr. Hersch has stock in Voyager Therapeutics. The institution of an immediate family member of Dr. Hersch has received research support from NIH. Dr. Hersch has received intellectual property interests from a discovery or technology relating to health care. |
No disclosure on file | |
No disclosure on file | |
Jan Nolta, PhD (University of California Davis) | No disclosure on file |